X
Please Wait
Applying Filters...
01 ANI PHARMS (6)
01 CAPSULE, EXTENDED RELEASE;ORAL (6)
01 RX (6)
01 DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (6)
01 No (6)
19
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 1.25MG;1.25MG;1.25MG;1.25MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
18
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 7.5MG;7.5MG;7.5MG;7.5MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
17
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 5MG;5MG;5MG;5MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
16
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 2.5MG;2.5MG;2.5MG;2.5MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
15
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 6.25MG;6.25MG;6.25MG;6.25MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
14
ANI Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 205401.
Regulatory Information RX
With a dosage strength 3.75MG;3.75MG;3.75MG;3.75MG
Dosage Form Route CAPSULE, EXTENDED RELEASE; ORAL
Reference Listed Drug No
Approved since 2019-01-22
Therapeutic Equivalence (TE) Code AB1
Market Place
